Quick Takeaways
- Squadron Capital Management LLC filed SCHEDULE 13G for Lipocine Inc. Common Stock, par value $0.0001 per share (LPCN).
- Disclosed ownership: 9%.
- Date of event: 18 Dec 2025.
Quoteable Key Fact
"Squadron Capital Management LLC disclosed 9% ownership in Lipocine Inc. Common Stock, par value $0.0001 per share (LPCN) on 18 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Squadron Master Fund LP | 8% | 444,632 | 0 | 444,632 | /s/ Matthew Sesterhenn | Partner, Squadron Partners LLC, its General Partner | |
| Squadron Capital Management LLC | 9% | 500,000 | 0 | 500,000 | /s/ Matthew Sesterhenn | Partner | |
| Matthew Sesterhenn | 9% | 500,000 | 0 | 500,000 | /s/ Matthew Sesterhenn | Matthew Sesterhenn | |
| William Blank | 9% | 500,000 | 0 | 500,000 | /s/ William Blank | William Blank |